Newswire (Published: Friday, June 25, 2021, Received: Friday, June 25, 2021, 3:45:01 PM CDT)
Word Count: 569
2021 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Defense & Aerospace Daily -- Current study results on Veterans Health have been published. According to news reporting originating from New York City, New York, by NewsRx correspondents, research stated, “In 2012, the United States Preventative Services Task Force (USPSTF) formally recommended against all prostate-specific antigen (PSA) screening for prostate cancer. Our goal was to characterize PSA screening trends in the Veterans Health Administration (VA) before and after the USPSTF recommendation and to determine if PSA screening was more likely to be ordered based on a veteran’s race or age.”
Funders for this research include US Department of Veterans Affairs, National Institutes of Health (NIH) - USA, Prostate Cancer Foundation (PCF), John and Daria Barry Precision Oncology Center of Excellence of the VANYHHS, Gertrude and Louis Feil Family Foundation, Edward Blank and Sharon Cosloy-Blank Family Foundation.
Our news editors obtained a quote from the research from New York University (NYU), “Using the VA Corporate Data Warehouse, we created 10 annual groups of PSA-eligible men covering 2009-2018. We identified all PSA tests performed in the VA to determine yearly rates of PSA screening. All statistical tests were 2-sided. The overall rate of PSA testing in the VA decreased from 63.3% in 2009 to 51.2% in 2018 (P < .001). PSA screening rates varied markedly by age group during our study period, with men aged 70-80 years having the highest initial rate and greatest decline (70.6% in 2009 to 48.4% in 2018, P< .001). Men aged 55-69 years had a smaller decline (65.2% in 2009 to 58.9% in 2018, P< .001) whereas the youngest men, aged 40-54 years, had an increase in PSA screening (26.2% in 2009 to 37.8% in 2018, P< .001). In this analysis of PSA screening rates among veterans before and after the 2012 USPSTF recommendation against screening, we found that overall PSA screening decreased only modestly, continuing for more than one-half of the men in our study. Veterans of different races had similar screening rates, suggesting that VA care may minimize racial disparities.”
According to the news editors, the research concluded: “Veterans of varying ages experienced statistically significantly differences in PSA screening trends.”
This research has been peer-reviewed.
For more information on this research see: The Association of Veterans’ Psa Screening Rates With Changes In Uspstf Recommendations. JNCI Journal of the National Cancer Institute, 2021;113(5):626-631. JNCI Journal of the National Cancer Institute can be contacted at: Oxford Univ Press Inc, Journals Dept, 2001 Evans Rd, Cary, NC 27513, USA.
The news editors report that additional information may be obtained by contacting Danil Makarov, New York University (NYU), Va New York Harbor Healthcare Syst, New York, NY 10016, United States. Additional authors for this research include Daniel J. Becker, Temitope Rude, Dawn Walter, Stacy Loeb, Shannon Ciprut, Matthew Kelly, Scott Sherman, Herbert Lepor, Chan Wang, Huilin Li, Joseph E. Ravenell, Steven B. Zeliadt and Angela Fagerlin.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1093/jnci/djaa120. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
(Our reports deliver fact-based news of research and discoveries from around the world.)
Veterans Health Administration
US Department of Veterans Affairs
National Institutes of Health
New York University
National Cancer Institute
Aerospace and Defense
New York City
Science and Technology
Health and Wellness
Medical Conditions and Diseases
Men's Health Issues
Politics and Government
Government Agencies (U.S.)
Department of Health and Human Services
National Institutes of Health
Department of Veterans Affairs